These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein. Gallea JI; Celej MS J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382 [TBL] [Abstract][Full Text] [Related]
11. Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality. Kumar J; Eraña H; López-Martínez E; Claes N; Martín VF; Solís DM; Bals S; Cortajarena AL; Castilla J; Liz-Marzán LM Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3225-3230. PubMed ID: 29531058 [TBL] [Abstract][Full Text] [Related]
12. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein. Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568 [TBL] [Abstract][Full Text] [Related]
13. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein. Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419 [TBL] [Abstract][Full Text] [Related]
14. The aggregation and fibrillation of alpha-synuclein. Fink AL Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679 [TBL] [Abstract][Full Text] [Related]
15. Influence of Lipid Membranes on α-Synuclein Aggregation. Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579 [TBL] [Abstract][Full Text] [Related]
16. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation. Chaari A; Eliezer D; Ladjimi M Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760 [TBL] [Abstract][Full Text] [Related]
17. Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles. John T; Gladytz A; Kubeil C; Martin LL; Risselada HJ; Abel B Nanoscale; 2018 Dec; 10(45):20894-20913. PubMed ID: 30225490 [TBL] [Abstract][Full Text] [Related]
18. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
19. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor. Afitska K; Priss A; Yushchenko DA; Shvadchak VV J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698 [TBL] [Abstract][Full Text] [Related]
20. Structural Characteristics of α-Synuclein Oligomers. Cremades N; Chen SW; Dobson CM Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]